LIVERMORE, Calif.–S2 Genomics, Inc., today announced that it has entered into a distribution agreement with Eisenberg for the promotion, sales, and support of S2’s Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in Israel. “Israel is a thriving market for single-cell genomics and cell biology research, creating a need for […]

RoosterBio, Inc., has entered an exclusive distributor partnership with MBL Beijing Biotech. We are thrilled to partner with the MBL Beijing team to accelerate the development of cell and exosome products and help deliver these innovative therapies to patients in China.” — Tim Kelly, CEO of RoosterBio FREDERICK, MARYLAND, UNITED STATES — RoosterBio, Inc., a […]

Newly released Evercode™ Whole Transcriptome v2 kits have demonstrably improved gene detection and robustness. SEATTLE –  Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a significant performance update of its chemistry for the Evercode™ Whole Transcriptome products. With substantial gains in transcript and gene detection alongside a more robust […]

Leading genomics solutions provider debuts complete NGS library preparation to support the identification of novel monkeypox variants in response to growing researcher demands for viral surveillance solutions CORALVILLE, Iowa — With the World Health Organization declaring the monkeypox virus (MPXV) a Public Health Emergency of International Concern, and more than 47,000 total cases across 99 […]

Oncomine Dx Express Test and Oncomine Reporter Dx informatics combine with Ion Torrent Genexus Dx System to deliver clinically relevant biomarker results in as little as one day CARLSBAD, Calif.– Next-generation sequencing (NGS) is quickly becoming the platform of choice for tumor molecular profiling due to its ability to simultaneously report on multiple biomarkers. However, […]

Investment in new Shanghai-based facility will allow the company to better serve its customers and meet growing demand SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the opening of its first manufacturing site in China. The new Shanghai-based facility enables localized production for Illumina’s gene […]

ROCKVILLE, MD – The American Society of Human Genetics (ASHG) today announced that the Illumina Corporate Foundation has awarded the Society a $175,000, one-year grant to support the ASHG Learning Center, a website portal that offers scientists from the genetics and genomics field access to professional education videos, webinars, workshops, and other content. Delivering year-round […]

Global conference to focus on advancing the life-saving impacts of genomic health care SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will feature International Tennis Hall of Fame member Chris Evert as a special guest at its inaugural Illumina Genomics Forum (IGF) on […]

Utrecht (the Netherlands) — The specialized private equity fund invests in scaling-up production and development of new medical tests Gilde Healthcare, a specialized healthcare investor, today announces its intention to acquire Sanquin Reagents from Sanquin Health Solutions (SHS) with its private equity fund. Sanquin Reagents produces and sells blood group and immune reagents, materials needed […]

Activator Protein 1 (AP-1) Assay Provides Researchers with Insight into Cancer and Inflammation State College, PA  – INDIGO Biosciences announced today the addition of a new cell-based firefly luciferase reporter assay for the Human Activator Protein 1 (AP-1) transcription factor. The new assay augments INDIGO’s existing collection of related transcription factor assays including Human NF-kB and Nuclear Factor of Activated […]